首页> 美国卫生研究院文献>Oncology Letters >Follicular dendritic cell sarcoma of the right tonsil: A case report and literature review
【2h】

Follicular dendritic cell sarcoma of the right tonsil: A case report and literature review

机译:右扁桃体滤泡性树突状细胞肉瘤1例并文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The current study presents a case of extranodal follicular dendritic cell sarcoma (FDCS) of the tonsil and reviews the relevant literature. In the present case, a 59-year-old male presented with a globus sensation in the right pharynx for 6 weeks. On clinical examination, a painless non-ulcerated enlarged right tonsil was identified; the tonsil was covered with a normal mucus membrane. A right tonsillectomy was performed under general anesthesia. The final pathological diagnosis was follicular dendritic cell sarcoma of the right tonsil. Postoperatively, the patient received radiotherapy. The patient remains alive without disease recurrence or metastasis 44 months after tonsillectomy. To the best of our knowledge, only 42 cases of FDCS of the tonsil have been reported to date. Of the 42 cases, 41 patients underwent surgery and one patient refused treatment. A total of 23 (54.7%) received surgery alone. Adjuvant treatment was administered for 18 patients (42.9%). Six patients (14.3%) experienced local recurrences and two patients (4.8%) succumbed to the disease 24 months after treatment. The three-, five-, and eight-year overall survival rates for the entire group were 86.5, 77.8 and 77.8%, respectively. Furthermore, a tumor diameter of ≥4 cm was prognostic upon univariate analysis (χ2=4.634; P=0.031; excluding incomplete data). Tonsillar FDCS is rare and is associated with high rates of recurrence and metastasis, therefore, adjuvant treatment should be prescribed.
机译:本研究提出了扁桃体结外滤泡性树突状细胞肉瘤(FDCS)的病例,并综述了相关文献。在本例中,一名59岁男性在右侧咽部出现了globus感觉,持续了6周。在临床检查中,发现无痛,无溃疡的右扁桃体肿大。扁桃体被正常的粘膜覆盖。在全身麻醉下进行右扁桃体切除术。最终病理诊断为右扁桃体滤泡性树突状细胞肉瘤。术后,患者接受了放疗。扁桃体切除术后44个月,该患者仍然存活,没有疾病复发或转移。据我们所知,迄今仅报告了42例扁桃体FDCS病例。在42例中,有41例接受了手术,其中1例拒绝了治疗。仅23例(54.7%)接受了手术。 18例患者(42.9%)接受了辅助治疗。治疗后24个月,六名患者(14.3%)经历了局部复发,两名患者(4.8%)死于该疾病。整个组的三年,五年和八年总生存率分别为86.5、77.8和77.8%。此外,单因素分析预后为肿瘤直径≥4cm(χ 2 = 4.634; P = 0.031;排除不完整的数据)。扁桃体FDCS很少见,并且与高复发率和转移相关,因此,应开辅助治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号